Markets.com Logo
markets.com

MSSS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

MSSS.US represents the common stock of Mereo BioPharma Group plc, a biopharmaceutical company focused on rare diseases. Mereo BioPharma develops and commercializes therapies for rare and specialty conditions, often targeting diseases with unmet medical needs. The company's strategy involves acquiring or in-licensing clinical-stage assets and advancing them through clinical development and potential commercialization. Investors in MSSS.US are exposed to the risks and potential rewards inherent in the biotechnology industry, including clinical trial outcomes, regulatory approvals, and market adoption of their therapies.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

S&P 500 Performance: MSSS.US tracks the S&P 500, so its price closely mirrors the index's overall movement.

Sector Performance: The performance of the healthcare sector, a significant component of MSSS.US, directly influences its price.

Interest Rates: Rising interest rates can make bonds more attractive, potentially drawing investors away from equities like MSSS.US.

Economic Data: Strong economic data often supports higher equity prices, while weak data can lead to declines in MSSS.US.

Investor Sentiment: Overall market optimism or pessimism significantly impacts demand for ETFs like MSSS.US.

Fund Flows: Large inflows into MSSS.US can push its price higher, while outflows can exert downward pressure.

Healthcare Policy: Changes in healthcare regulations and policies can substantially affect the profitability and valuation of healthcare companies within MSSS.US.

Inflation: High inflation can erode corporate profits and diminish investment returns, potentially affecting MSSS.US's price negatively.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com